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Abstract
The concept of self and self-referential processing has a growing explanatory value in
psychiatry and neuroscience, referring to the cognitive organization and perceptual dif-
ferentiation of self-stimuli in health and disease. Conditions in which selfhood loses its
natural coherence offer a unique opportunity for elucidating the mechanisms underly-
ing self-disturbances. We assessed the psychoactive effects of psilocybin (230 μg/kg
p.o.), a preferential 5-HT1A/2A agonist known to induce shifts in self-perception. Our
placebo-controlled, double-blind, within-subject crossover experiment (n = 17)
implemented a verbal self-monitoring task involving vocalizations and participant iden-
tification of real-time auditory source- (self/other) and pitch-modulating feedback. Sub-
jective experience and task performance were analyzed, with time-point-by-time-point
assumption-free multivariate randomization statistics applied to the spatiotemporal
dynamics of event-related potentials. Psilocybin-modulated self-experience, interacted
with source to affect task accuracy, and altered the late phase of self-stimuli encoding
by abolishing the distinctiveness of self- and other-related electric field configurations
during the P300 timeframe. This last effect was driven by current source density
changes within the supragenual anterior cingulate and right insular cortex. The extent
of the P300 effect was associated with the intensity of psilocybin-induced feelings of
unity and changed meaning of percepts. Modulations of late encoding and their under-
lying neural generators in self-referential processing networks via 5-HT signaling may
be key for understanding self-disorders. This mechanism may reflect a neural instantia-
tion of altered self–other and relational meaning processing in a stimulus-locked time
domain. The study elucidates the neuropharmacological foundation of subjectivity,
with implications for therapy, underscoring the concept of connectedness.
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1 | INTRODUCTION
Self refers to one's identity and the demarcated subject of experience.
The concept has received notable interest across diverse research areas,
ranging from philosophy (Metzinger, 2004; Zahavi, 2010) to psychiatry
(Kircher & David, 2003) and neuroscience (Chen & Huang, 2017;
Christoff, Cosmelli, Legrand, & Thompson, 2011). As recognizing “me”
from “not me” is a fundamental principle of an intact sense of self
(Decety & Sommerville, 2003), a key research focus has been the mecha-
nisms underlying the differentiation between self- and other-related
stimuli. Neuroscientific studies using electroencephalography (EEG) and
magnetoencephalography to index event-locked cortical responses sug-
gest that sequential (from early sensory to more semantic) brain pro-
cesses are implicated in this differentiation (Walla, Duregger, Greiner,
Thurner, & Ehrenberger, 2008). Previous experiments have indicated
that the neural processing of self-related stimuli differs from other-
related stimuli within as soon as 100–200 ms. The former tend to have
lower amplitudes of the N1/N170 event-related potential (ERP), while
the latter tend to have higher amplitudes of the P2/N2 ERP (Caharel
et al., 2002; Keyes, Brady, Reilly, & Foxe, 2010). These differences are
critically engaged in the early detection of physical features (Krumbholz,
Patterson, Seither-Preisler, Lammertmann, & Lütkenhöner, 2003;
Obleser, Scott, & Eulitz, 2006). This stage seems to reflect automatic
sensory-feedback mechanisms (Heinks-Maldonado, Mathalon, Gray, &
Ford, 2005) for detecting expected, prioritized, and overlearned input
associated with the self (e.g., one's own voice). During a later processing
phase of the P300 component (peaking within 300–600 ms), neural sig-
natures from self-related stimuli were also found to differ from other-
related stimuli (with typically higher amplitudes for the former), reflecting
distinct activity in frontoparietal circuits (Knyazev, 2013) implicated in
further elaborative processes and cognitive categorization (Polich, 2012).
For example, a larger P300 amplitude was found for the sound of one's
own name versus other words (Berlad & Pratt, 1995), self-referent ver-
sus unrelated possessive pronouns (Zhou et al., 2010), and autobiograph-
ical memories versus other memories (Gray, Ambady, Lowenthal, &
Deldin, 2004), suggesting a processing bias for stimuli pertaining to the
self. Notably, a disruption of those two processing stages has been impli-
cated in the pathophysiology of psychiatric symptoms, such as schizo-
phrenia (Bühler et al., 2016; Qiu, Tang, Chan, Sun, & He, 2014), bipolar
disorder (Zhao, Luo, et al., 2016; Zhao, Yao, et al., 2016), and depression
(Tripathi, Mishra, Tripathi, & Gurnani, 2015).
Despite this progress in our understanding of the spatiotemporal
brain dynamics of self–other differentiation, its neuropharmacological
underpinnings, possible modulators, and corresponding subjective
effects remain largely unknown. To further elucidate these questions,
we administered the serotonergic agonist psilocybin (vs. placebo) to
healthy human subjects and quantified their spatiotemporal brain activ-
ity using EEG in combination with topographic analysis of variance
(TANOVA). Serotonin signaling and 5-hydroxytryptamine 2A (5-HT2A)
receptors in particular might be implicated in self–other differentiation,
as classic psychedelics, such as psilocybin (4-phosphoryloxy-N,N-dimeth-
yltryptamine, https://pdsp.unc.edu/pdspweb/), have been shown to
induce marked alterations in the experience of self (Studerus, Kometer,
Hasler, & Vollenweider, 2011). One salient aspect of psychedelic effects
is so-called ego-dissolution, a state of perceived blurred demarcation
between self and non-self (Dittrich, 1998; Letheby & Gerrans, 2017; Pre-
ller & Vollenweider, 2016). Moreover, psilocybin was found to alter
internally and externally induced neuronal activity (in association with
drug-attenuated alpha oscillations and a resulting imbalance of excitabil-
ity in the absence or presence of an external stimulus) (Kometer,
Schmidt, Jäncke, & Vollenweider, 2013) and also to modulate the
N1/N170 (Bravermanová et al., 2018; Kometer et al., 2013; Kometer,
Cahn, Andel, Carter, & Vollenweider, 2011; Umbricht et al., 2003) and
P300 components (Bravermanová et al., 2018; Kometer et al., 2012) via
5-HT2A receptor activation. Furthermore, altered delta oscillations,
which are crucial for the P300 component (Güntekin & Başar, 2016),
have been previously associated with aberrant self-experience (Carhart-
Harris et al., 2016; Kometer, Pokorny, Seifritz, & Volleinweider, 2015).
Given that these observed psilocybin-induced modulations of neural
mechanisms are thought to underlie self-referential processing, it is con-
ceivable that the ego-dissolution effect is mediated by an altered self–
other (i.e., source) differentiation, with corresponding differences in the
spatiotemporal properties of the N100 or/and P300 ERPs. To test this
hypothesis, we quantified the psychotropic effects of psilocybin in
healthy subjects performing a self-monitoring task involving speech pro-
duction with feedback varying in source (self vs other) and pitch (intro-
duced to increase response variation and task difficulty) on three
different levels: experiential, behavioral, and neural. These assays
included subjective drug effects, voice recognition and misattribution,
and cortical responsiveness to self- and non-self-related stimuli,
respectively.
2 | MATERIALS AND METHODS
2.1 | Experimental design
The study employed a double-blind, placebo-controlled, within-
subject design with a counterbalanced order of administration.
2.2 | Participants
Seventeen healthy right-handed individuals (9 males, mean age
25.1 ± 4.1 years, mean verbal IQ 104.9 ± 10.7) were included in the
analysis (details on recruitment and exclusion/inclusion criteria as well
as a study flow diagram are given in the Supplementary Material,
pp. 2–3). Written consent was obtained from subjects before enroll-
ment. The experiment was approved by the Cantonal Ethics Commit-
tee of Zurich, Switzerland.
2.3 | Drug and dosing
Psilocybin (230 μg/kg body weight, mean body weight of subjects
71.5 ± 16.5 kg) and placebo (lactose) were administered in capsules of
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identical appearance on two experimental days separated by at least
2 weeks to minimize carry-over effects. The use of psilocybin was
authorized by the Swiss Federal Office for Public Health, Department
of Pharmacology and Narcotics, Bern, Switzerland.
2.4 | Psychometrics
Drug effects were measured by the Altered States of Consciousness
rating scale (5D-ASC) (Dittrich, 1998; Dittrich, Lamparter, &
Maurer, 1999), using 11 previously empirically extracted scales
(Studerus, Gamma, & Vollenweider, 2010). The present analysis spe-
cifically utilized three self-related processing dimensions reflecting
(a) alterations in self-experience, that is, feelings of unity, (b) lessened
bodily reference, that is, disembodiment, and (c) altered attribution of
meaning, that is, changed meaning of percepts, as well as one additional
aspect related to audio-visual changes (i.e., audio-visual synesthesia;
multisensory perceptual experiences), which was considered based on
the task modality. The changed meaning dimension was included
because the attribution of personal relevance to external stimuli may
convey an important aspect of self-relatedness (Northoff &
Hayes, 2011). In addition, our previous functional magnetic resonance
imaging (fMRI) studies identified prominent acute changes in this
domain caused by psychedelic drugs and related to self-related
processing (Preller et al., 2017; Preller et al., 2018).
2.5 | Task and procedures
The experiment started 75 min post-administration, corresponding to
the beginning of the plateau of peak subjective effects produced by
orally administered psilocybin (Hasler, Grimberg, Benz, Huber, &
Vollenweider, 2004). Each trial was initiated with a visual cue “A,”
after which subjects pronounced the sound [a:] for about 1 s and
received real-time audio feedback that varied between the partici-
pant's own unaltered voice, the participant's pitch-shifted voice, an
unaltered “other” voice, and a pitch-shifted “other” voice. The pitch
shifting was integrated into this self-monitoring task to introduce suf-
ficient variation and to increase task difficulty. After each trial, sub-
jects indicated via key press whether they heard their own voice, the
voice of someone else, or whether they were unsure. Importantly,
they were instructed to choose the “self” response whenever they
recognized their own voice, even when it was pitch-shifted. The visual
stimuli (i.e., the vocalization cue, rating board, and fixation cross) were
presented in black text on a white screen. A centrally situated fixation
cross was shown for 1.2 s between each trial. The inter-trial interval
was variable and dependent on the response reaction time. A reaction
was required within 5 s after the prompt, and responses after this
time were considered missing data. An internal trigger pulse marking
the onset of vocalization was generated on the rising edge of the
incoming audio signal and activated the experimental conditions. For
the “other” condition, the participant's voice was substituted with a
previously recorded sample of a male or female utterance of the
sound [a:] (for male or female participants, respectively). The pitch-
shifting of two semitones downwards was implemented in real time
for the unaltered speech and added ahead of time for the prerecorded
other voice using the same algorithm. In order to dampen the external
auditory feedback and mask bone conduction effects, a pink (1/f )
background noise of 60 dB was constantly played over the earphones.
The volume level was maintained at 87–93 dB. An external trigger
pulse marking the onset of vocalization was sent through the parallel
port to the EEG data collection system for analysis.
A total of 280 trials, with 70 randomly ordered trials per condi-
tion, were conducted. More details on the study procedures and the
technical equipment are given in the Supplementary Material (pp. 4–5).
2.6 | EEG recording and preprocessing
EEG was recorded with the BioSemi Active Two acquisition system
using 64 Ag/AgCl scalp electrodes (BioSemi, Amsterdam, The Neth-
erlands). Additional electrodes were placed on the outer canthus of
each eye and supraorbitally and infraorbitally with respect to the left
eye in order to record horizontal and vertical electrooculography.
The recording sampling rate was 2048 Hz. The preprocessing was
performed using BrainVision Analyzer 2.1 (Brain Products, Munich,
Germany). The signal was down-sampled after recording to 512 Hz
and band-pass-filtered between 0.5 Hz (12 dB/octave slope) and
20 Hz (48 dB/octave slope). Eye movements were removed from
the signal by extended infomax (independent component analysis)
and channels with noise were interpolated by spherical splines. Data
were segmented into epochs spanning 200 ms prestimulus to
800 ms poststimulus, and sweeps exceeding 80 ± μV and gradients
exceeding 30 μV/ms were excluded from further analyses. The
mean ± SD of accepted epochs per condition were as follows: for
placebo, 67.7 ± 2.0 ms (self ), 68.6 ± 1.3 ms (self pitch-shifted),
68.9 ± 1.3 ms (other), and 68.9 ± 1.4 ms (other pitch-shifted); for psi-
locybin, 65.6 ± 3.7 ms, 66.8 ± 3.5 ms, 67.4 ± 3.1 ms, and
66.8 ± 4.5 ms (respectively). Finally, the epochs were averaged and
baseline corrected from −200 to 0 ms. Data were also inspected
visually to confirm the accuracy of automated procedures. The aver-
age reference was used for analysis. Data were analyzed from
61 channels, forming a uniform spherical head model (without P10,
P9, or Iz).
2.7 | Analysis of subjective drug effects and
behavioral responses
A multinomial logistic regression was used to estimate the probability
of correct, incorrect, and unsure responses in the behavioral task
dependent on the drug treatment and experimental condition of
source (“self”/“other”) and pitch (“unaltered”/“pitch-shifted”). As the
marginal count of missing responses was particularly low (0.17% and
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0.99% of all responses for the placebo and psilocybin groups, respec-
tively), these responses were not considered in the analysis. Two
models were used to analyze the data: Model 1 was fitted with all the
data, and Model 2 was fitted only with data based on unaltered voices
(i.e., without pitch conditions), as our key interest was the genuine
self–other contrast. The hypothesis assumed that the acute treatment
with psilocybin, compared to placebo, would cause a decline in task
accuracy manifested as an interaction with source, by blurring differ-
entiation between the “self” and “other” stimuli. The significance level
was set at p < .05.
2.8 | General analysis approach to EEG data
Quantitative statistical inferences about neural events and their gen-
erators under experimental conditions were conducted using random-
ization statistics for the whole-brain signal without assuming any a
priori models, such as a particular set of channels or specific time win-
dow. The approach combined computational methods, as
implemented in the MATLAB-based Randomization Graphical User
Interface (RAGU) software-package (Habermann, Weusmann, Stein, &
Koenig, 2018; Koenig, Kottlow, Stein, & Melie-García, 2011), which is
designed to analyze multichannel ERP data using randomization statis-
tics. The analysis was conducted for the main conditions of interest,
that is, treatment (psilocybin/placebo) and source (self/other; without
pitch alterations, as we were specifically interested in the genuine
source effects), as factors. For the randomization tests (topographic
consistency test [TCT], TANOVA, and topographic analysis of covari-
ance (TANCOVA)], 5,000 permutations (Manly, 2006) were performed
over the whole 800-ms poststimulus window, with a significance
threshold of p < .05. While evaluating time windows, to account for
temporal autocorrelation and multiple comparisons, the global dura-
tion statistics, as part of the RAGU software, were applied, using
5,000 randomized permutations with an alpha level of p = .05
(i.e., accepting periods longer than 0.95 of all randomly obtained
effect durations) (Habermann et al., 2018).
2.9 | Analysis of topographic configuration
In the first step, a TCT based on global field power (GFP) was used to
evaluate the stability of voltage configurations, providing support (or a
lack of support) for consistent neuronal sources (Koenig & Melie-
García, 2010). The test compares the GFP of an ERP for each time
point with the GFP distribution at the same time point by randomly
shuffling the data for each individual voltage value. The GFP is a quan-
tifier of field strength regardless of topographic modulations, calcu-
lated as the root of the mean of the squared potential differences
across all sensors ðGFP= √ PN
i=1
vi− v̂ið Þ
 
2NÞ (Lehmann & Skrandies,
1980). The derived Monte Carlo p-value reflects the level of probabil-
ity with which the given configuration could have been generated by
chance. Subsequently, data were subjected to a TANOVA (Strik,
Fallgatter, Brandeis, & Pascual-Marqui, 1998). This is a nonparametric
randomization procedure that calculates global dissimilarities between
experimental factors in electric scalp fields in the ERP grand means
for each sampling point and tests the probability of these dissimilar-
ities occurring under the null-hypothesis. Since the difference in spa-
tial distribution implies at least partially varying functional
mechanisms, the test may allow for their disentanglement (Koenig
et al., 2011). The two-factorial design used a randomization procedure
where each factor (treatment, source) was permuted separately.
Because a fully free randomization may decrease the sensitivity for
detecting an effect of a weaker factor (Koenig et al., 2011), the per-
mutations were constrained such that each factor competes only
against the permutations of itself and not against those of the other
factor. Significant TANOVA effects were followed by construction of
post hoc t-maps and a multidimensional scaling method to further
explore the spatial distribution of differences.
2.10 | Link between neural data and subjective
drug effects
A TANCOVA (Koenig et al., 2011) was conducted to test whether and
in which time window and scalp configuration a behavioral continuous
variable co-varied linearly, using bootstrapping and randomization statis-
tics. The method considers ERPs to be superimposed on a topographic
map whose contribution to the ERP is proportional to external variables.
This analysis was used to determine whether there was a consistent set
of sources being activated in proportion to the drug effects. The calcula-
tion was performed on the difference in L2-normalized ERPs between
both “self” placebo and psilocybin and “other” placebo and psilocybin
conditions as well as the difference in scores between placebo and psi-
locybin treatment, as measured by the ASC scale.
2.11 | Source estimations
As differences in scalp topographic configurations must result from
somewhat dissociable underlying neural generators, standardized low-
resolution brain electromagnetic tomography (sLORETA) (Pascual-
Marqui, 2002), a well-established source localization method, was
used to approximate putative brain areas within the drug by source
interaction time window as determined by TANOVA. A paired test
with 5,000 permutations was used to examine whether (A1–A2) = (B1–
B2), where A1 and A2 are log-transformed self and other values,
respectively, for the placebo treatment, and B1 and B2 are self and
other values, respectively, for the psilocybin treatment. sLORETA is
an inverse solution approach for computing the smoothest of the pos-
sible three-dimensional intracerebral distributions of the current
source density (CSD), based on the MNI152 template and 6,239
voxels (5 × 5 × 5 mm) covering the gray matter. The regularization
parameter (signal-to-noise ratio) was set to 100, but other values gave
very similar results. The results were assessed with a two-tailed t-test
at a p < .05 threshold.
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3 | RESULTS
3.1 | Subjective effects of psilocybin
First, we analyzed the subjective effects of placebo versus psilocybin
treatment. Psilocybin-modulated 5D-ASC scores, as indicated by the
significant interaction between drug and scale (F10,160 = 16.71, p <
.0001), as well as main effects of scale (F10,160 = 17.29, p < .0001) and
treatment (F1,16 = 83.05, p < .0001). With the exception of anxiety
(p = 0.999) and spiritual experience subscale scores (p = .991), post
hoc Tukey's HSD tests revealed a significant increase for all other sub-
scale scores after psilocybin administration compared to placebo (for
insightfulness, p = .024; for all others, p < .0001) (Figure 1).
3.2 | Self-monitoring task performance
We also investigated the impact of treatment with psilocybin on
behavioral responses in the task, testing the key hypothesis of the sig-
nificance of a treatment by source interaction. The number of correct,
incorrect, and unsure responses for the placebo group were 3,823
(80.43%), 628 (13.21%), and 302 (6.35%) versus 3,442 (73.03%),
911 (19.33%), and 360 (7.64%) for the psilocybin group, respectively.
The results of the multinomial logistic regression are reported in
Table 1, showing which predictors have a significant effect on the
response. Conforming with our hypothesis, the positive coefficients
and significant p-values for Models 1 and 2 (β = .373, p = .004; β = .676,
p = .003) suggest the probability of responding inaccurately increases
under psilocybin treatment. This interaction effect is plotted in Figure 2,
indicating that drug had a bigger effect on correct and incorrect
responses when the source voice was “self” than when the source was
“other,” as represented by the difference in line slopes. The drug itself
increased the probability of false recognitions in the model including pitch
(β = .330, p = .004), but this effect became nonsignificant when pitch was
discarded from the analysis (β = .223, p = .084). Drug alone had no signifi-
cant effect on unsure responses. Separately, an interaction of treatment,
source, and pitch was tested by including a triple interaction term in the
model, yielding nonsignificant results (β = .264 and p = .085, for incorrect
and unsure responses).
3.3 | Analysis of scalp topographies
Before performing TANOVA, we investigated the consistency of scalp
electroencephalogram maps. The TCT (Figure 3a) indicated consistent
activation for most of the 800-ms period apart from the following
intervals: 362–370 ms, 740–800 ms (placebo self), 231–363 ms,
731–780 ms (placebo other), 401–452 ms, 709–800 ms (psilocybin
self), 157–186 ms, 301–394 ms, and 746–800 ms (psilocybin other).
Since there was no evidence that the experimental conditions elicited
verifiable scalp configurations, effects within these timeframes were
not considered for further analyses.
The TANOVA results, corresponding topographic maps, and t-maps
are depicted in Figure 3b–d, respectively. The TANOVA revealed a sig-
nificant main effect of drug from 75 to 105 ms postvocalization onset.
The corresponding t-map in this timeframe was characterized by left
anterior positivity (tmax at FT7 = 2.406) and right posterior negativity (tmin
at P4 = −3.090). A significant main effect of source was found very early,
between 52 and 77 ms, with t-maps of almost symmetric frontal positiv-
ity and negativity propagating posteriorly (tmax at FT8 = 2.630, tmin at
PO4 = −2.743). Late components included the 475–498 ms (tmax at
FC2 = 3.079, tmin at T8 = −6.389), 550–577 ms (tmax at C1 = 3.034, tmin
at T8 = −5.047), and 620–644 ms (tmax at CP2 = 3.332, tmin at
FT8 = −5.100) time windows, with a characteristic positivity moving
F IGURE 1 Subjective effects of
psilocybin as measured along
11 dimensions of the Altered States of
Consciousness rating scale (5D-ASC).
Scores are percentages of the scale
maximum. Values are means and SEs
with significance levels of Tukey's
HSD tests as shown: **, p < .0001; *,
p < .05; ns., not significant
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around the midline anterior to posterior areas, together with coexistent
bilateral parietal negativities. A significant drug by source interaction was
identified for the time window between 452 and 520 ms, which was also
the longest period of significance. The interaction revealed when the
effect occurred but did not determine which conditions accounted for
it. Figure 4a–d presents further exploration of the interaction effects.
Importantly, a series of post hoc t-map contrasts (Figure 4b) provided
more insight into this effect by showing that the scalp configurations
between “self” and “other” differed significantly for placebo (p = .017,
tmax at Cpz = 4.580, tmin at TP7 = −5.728), but not for psilocybin or other
contrasts (p > .270; uncorrected p across four comparisons).
3.4 | Current source densities
In order to discover more about the actual neural generators underly-
ing the interaction effect, we interrogated this question using whole
scalp data in the inverse space within the identified time window
(452–520 ms). This showed significant modulations in CSD under psi-
locybin for k = 249 voxels (5 × 5 × 5 mm) localized primarily in the
supragenual anterior cingulate (x = 0, y = 25, z = 35; x = 0, y = 25,
z = 25), indicating a decrease for the “other” condition under psilocy-
bin. Another concentrated cluster of suprathreshold voxels was found
in the right insula (x = 50, y = −30, z = 20), with increases in CSD for
the “self” condition under psilocybin. There was also an effect local-
ized in the right superior temporal lobe (x = 65, y = −20, z = 10), in the
right primary auditory cortex (Brodmann area 42), indicative of atten-
uated activity for psilocybin. The significant suprathreshold clusters
from this analysis are depicted in Figure 4d, along with plots showing
the extracted values according to treatment, source, and brain area.
3.5 | Link between neurophysiology and subjective
effects of psilocybin
Finally, we investigated the association between scalp signal and drug
effects. The TANCOVA of the difference between “self” conditions
revealed significant effects for the feeling of unity (447–472 ms),
changed meaning of percepts (485–520 ms), and disembodiment
(94–130 ms) (Figure 5). These significant associations (p < .05) occurred
over intervals exceeding 20 ms, which we considered reliable and suffi-
ciently accounting for temporal autocorrelation in this permutation-
based analysis (Guthrie & Buchwald, 1991), as applied in previous stud-
ies applying this method (Lancheros, Jouen, & Laganaro, 2020; Liverani
et al., 2015). The initial 5 ms for the effect on the feeling of unity
occurred in a period of inconsistent topographies based on the TCT.
None of the “other” conditions were significant, apart from dis-
embodiment in the time window between 335 and 370 ms, which was
discarded because of inconsistent topographies.
4 | DISCUSSION
The present human study, using a placebo-controlled, within-subject
design, examined the effects of a potent psychedelic, psilocybin, on
self–other distinctions during a verbal self-monitoring task. First, we
TABLE 1 Parameter estimates of the multinomial logistic regression analysis in the self-monitoring task (z-test of coefficients)
Predictor
Model 1 Model 2
Estimate SE z Pr(>jzj) Estimate SE z Pr(>jzj)
Incorrect (intercept) −2.127 0.090 −23.520 <2.2e-16*** −2.069 0.095 −21.801 <2.20e-16***
Incorrect: Treatment drug 0.330 0.114 2.890 0.004** 0.223 0.129 1.726 0.084
Incorrect: Source self −0.955 0.134 −7.136 <9.59e-13*** −1.141 0.181 −6.316 <2.694e-10***
Incorrect: Pitch-shift 0.039 0.118 0.332 0.740
Incorrect: Treatment drug × source self 0.373 0.128 2.912 0.004** 0.676 0.226 2.989 0.003**
Incorrect: Source self × pitch-shift 2.252 0.134 16.837 <2.2e-16***
Incorrect: Treatment drug × pitch-shift −0.012 0.135 −0.091 0.928
Unsure (intercept) −2.717 0.118 −23.096 <2.2e-16*** −2.594 0.121 −21.522 <2.2e-16***
Unsure: Treatment drug 0.245 0.148 1.654 0.098 0.006 0.172 0.038 0.970
Unsure: Source self −0.159 0.154 −1.035 0.301 −0.431 0.185 −2.327 0.020*
Unsure: Pitch-shift −0.072 0.154 −0.468 0.640
Unsure: Treatment drug × source self −0.371 0.167 −2.220 0.026* 0.169 0.259 0.652 0.514
Unsure: Treatment drug × pitch-shift 0.444 0.170 2.616 0.009**
Unsure: Source self × pitch-shift 1.074 0.170 6.337 2.34e-10***
Note: The z-statistic reflects the ratio of the coefficient to the SE of the predictor, while Pr > jzj is the corresponding p-value. The reference level was set to
correct responses. Model 1 includes the whole data set, while Model 2 includes only the non-pitch-shifted conditions.
***p <.0001.
**p < .001.
*p < .05.
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measured the self-reported acute changes in consciousness and per-
ception, and subsequently, we assessed the behavioral task responses.
Furthermore, we investigated the whole scalp ERPs from the task, as
well as the relationship between electrophysiology and subjective
drug effects. As the key finding, the spatiotemporal analysis of the
EEG signal during the whole epoch (0–800 ms) revealed that psilocy-
bin lessened distinct self- and other-related neural scalp configura-
tions during the P300 timeframe (452–520 ms) compared to placebo.
This interaction effect involved modulations of CSD in brain regions
typically associated with self-processes, including the anterior cingu-
late and insular cortex. Moreover, neural alterations in self-processing
induced by psilocybin co-varied with drug-induced subjective effects
(including feeling of unity and changed meaning) within the same
P300 time window. These results support the association of these
neuronal mechanisms with psilocybin-induced alterations in self-
experience.
4.1 | Behavioral responses
The analysis of the judgment-based behavioral ratings in the self-
monitoring task indicated an interaction effect between the action
of psilocybin and the “self” and “other” categories on speech attribu-
tion accuracy. Specifically and critically, under the pharmacological
stimulation, the probability of attributing the “self” voice to the “self”
source dropped significantly more than the probability of
F IGURE 2 Response probability
visualized as treatment by source
interaction effects in the self-monitoring
task. Three formats of responses (correct,
incorrect, unsure) are depicted on the plot
as dependent on the source (“self,”
“other”) and treatment (placebo,
psilocybin). Model 1 (a) includes all data,
and Model 2 (b) discards the pitch-shifted
conditions
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recognizing the “other” voice as “other.” This finding confirms the
hypothesis being tested and guiding the present work, which posits
an alteration in self-referential processing caused by the drug.
Reports of psilocybin-induced aberrant self-experience, lessened
ego-centricity, or even states of “selflessness,” particularly under
higher doses can be found in recent research literature (Smigielski,
Kometer, et al., 2019; Smigielski, Scheidegger, Kometer, & Vollenweider,
2019). Impaired self-monitoring for speech production and recognition
suggests affected mechanisms of cognitive control and motor-to-
sensory transformations (Nozari & Novick, 2017), but it may also reflect
a unique profile of psychedelic compounds altering self-related pro-
cesses. Interestingly, a proneness to misattribute speech or externaliza-
tion biases during self-monitoring tasks has been linked to delusions and
hallucinations in disease (Allen et al., 2004; Allen, Freeman, Johns, &
McGuire, 2006), as is often induced (although more in the form of
pseudo-hallucinations) by psychedelic drugs such as psilocybin (Studerus
et al., 2011).
4.2 | Neural responses: Topographical
configurations
In agreement with the behavioral responses from the self-monitoring
task, there was also a significant drug by source interaction for the
neural data during the P300 processing stage. Post hoc t-maps rev-
ealed a significant self–other difference in topographical configurations
F IGURE 3 Topographic comparison for the whole epoch (0–800 ms) for treatment (placebo/psilocybin) and source (self/other). (a) Results of
the topographic consistency test (TCT) for all four conditions with time windows in green marking significant effects (only these were considered
for further analyses). The upper black curve represents the global field power (GFP) amplitude (in μV), the lower vertical line corresponds to the
p-value of .05, and the height of gray areas indicates the TCT p-value. (b) Timeframes in white depict periods over which the null hypothesis
probability p in the topographic analysis of variance (TANOVA) (y-axis) as a function of time (x-axis) was below .05; timeframes in yellow were
during periods of consistent scalp configurations (those meeting the a priori criterion of duration <20 ms, to account for autocorrelation); the
timeframe in blue meets the data-driven criterion of global duration statistics. (c) Topographies of main effects and interactions. The arrows link
the found time windows with the corresponding topographic maps. (d) T-maps contrasting significant main effects (placebo > psilocybin,
self > other). The interaction effect is depicted further in detail in Figure 4. (e) Global duration statistics for the main effects of Factor
1 (treatment), Factor 2 (source), and their interaction. Only the interaction time window (452–520 ms) met the duration statistics criterion
(>52.73 ms)
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under placebo, while no such differences occurred under psilocybin
(Figure 4b). Analogously, multidimensional scaling, which enables the
visualization of similarities among datasets as Euclidean distances in
low-dimensional space, showed that self- and other-related processing
under psilocybin was associated with much more similar underlying
neural events compared to placebo (Figure 4a). Additionally, visual
inspection of waveforms for canonical P300 electrodes indicated over-
laps in the significant time window (Figure 4c), suggesting a blurred dif-
ferentiation between percepts of both self and other. This finding
indicates that psilocybin alters self–other differentiation primarily by
dissolving the neuronal differences between self and other during late
(P300) processing stages.
Using TANCOVA, significant effects were observed for changed
meaning of percepts and feeling of unity during the P300 timeframe
(Figure 5); the former reflects a proneness to attribute changed mean-
ing to perceptual events, while the latter suggests undifferentiated
cognition between self and non-self/other. We detected changes that
coincided and covaried with the magnitude of subjective drug-induced
effects within the same timeframe, which further strengthens the evi-
dence for psilocybin altering ordinary self-experience. This comports
with previous fMRI results showing the psychedelic substance LSD altered
self- and other-initiated social interactions and was associated with
changes in meaning attribution (Preller et al., 2017; Preller et al., 2018).
Based on these and other findings, we believe that meaning attribution is
intrinsically tied to self-processes through self-relatedness, reward effects,
and the valuation systems of organisms (de Greck et al., 2008; Northoff &
Hayes, 2011). More broadly, altered meaning processing may be a key
mechanism stimulating the putative therapeutic action of psychedelic
compounds (Hartogsohn, 2018). Here, we specifically identified P300 as
the time window associated with psilocybin-induced subjective effects on
the self, also supporting the established role of P300 in self-referential
processing (Knyazev, 2013).
F IGURE 4 Detailed exploration of the topographic analysis of variance (TANOVA) interaction effects (452–520 ms). (a) The interaction found
by the TANOVA was input into a multidimensional scaling (MDS) analysis by submitting all mean maps to a spatial principal component analysis
(PCA). The spatial distribution of the eigenvector is represented by topographies along the x- and y-axes. The MDS indicated that the drug by
source interaction is primarily associated with a high difference between self and other for the placebo treatment, which is much smaller than
that for the psilocybin treatment. (b) Post hoc t-maps of interaction contrasts. Note that only the t-map for self > other for the placebo treatment
is significant (with maximal positivity in Cpz), while no significant difference was evident for self > other for the psilocybin treatment nor the
other contrasts. (c) Illustration of waveforms recorded from Cpz (detecting maximal positivity in the aforementioned contrast) and Pz (cardinal
neighboring sensor) electrodes (black, self; red, other; violet, 452–520 ms). (d) Estimates of current source densities, by calculating voxel-by-voxel
paired self–other differences using standardized low-resolution electromagnetic tomography (sLORETA). Significant source density differences
are depicted in red (p = .012, corrected for multiple comparisons by the Nichols and Holmes method). Suprathreshold voxels were found primarily
in the supragenual anterior cingulate (tmax = 4.82) and right insula (tmax = 4.06), as well as in the right superior temporal gyrus (tmax = 4.30).
Maximal source density estimations are marked with arrows. The plots depict the current source density (CSD) values exported from the three
main clusters
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4.3 | Neural responses: CSDs
To further explore the spatiotemporal dynamics of the drug by source
interaction, source localization was conducted during the detected P300
timeframe, revealing the underlying modulations of CSD in the supra-
genual anterior cingulate, right insular cortex, and right auditory cortex.
Previous studies suggest that once represented in the orbitomedial pre-
frontal cortex, self-referential stimuli are processed in the supragenual
anterior cingulate, which subserves monitoring functions (Northoff &
Bermpohl, 2004). Higher activity in this region was found for self-
referential compared to non-self-referential stimuli (Frith & Frith, 1999),
irrespective of sensory modality or task (Northoff & Bermpohl, 2004).
Accumulated evidence supports a pivotal role of cortical midline struc-
tures as the neural basis of the self (Qin & Northoff, 2011). In our study,
for psilocybin, CSD was lower in response to the “self” voice than the
“other” voice, indicative of dissimilar self–other processing. CSD
exhibited a marked decrease in the “self” category from the placebo to
psilocybin treatments in the right insula. Previous studies identified the
insula within an extended self-network (Modinos, Ormel, & Aleman, 2009),
consistent with it being considered the convergence zone for global self-
representation, through its role in recognizing self–other boundaries, owing
to its engagement in interoception, multisensory integration, and self-
processing (Tajadura-Jiménez & Tsakiris, 2014). The additional lower CSD
in the right auditory cortex for psilocybin also suggests its reduced engage-
ment. In general, the spatial pattern of our finding coincides with the distri-
bution of 5-HT2A and 5-HT1A receptors (the main psilocybin binding sites),
which are highly present in the fronto-medial neocortex and insular cortex
neurons of the superficial and middle laminae (Stein et al., 2008; Talbot
et al., 2012). Thus, psilocybin appears to alter self–other differentiation by
modulating spatiotemporal activity in those structures typically involved in
self-referential processing.
4.4 | Comparisons with other studies on altered
self–other processing
Our results may be juxtaposed with previous studies on perceived
self–other boundaries, investigating the effects of the neuropeptide
F IGURE 5 Results of a topographic analysis of covariance (TANCOVA). Five thousand iterations per time point were calculated for the
placebo–psilocybin difference for self conditions and for subjective effects from the Altered States of Consciousness rating scale (5D-ASC).
White fields under the curve indicate periods over which the null hypothesis probability p was below .05. The regression plots on the right
illustrate the individual strength of the covariance map with scale values along the y-axis as arbitrary electroencephalography (EEG) units
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oxytocin and mindfulness training. Oxytocin was found to blur the
self–other differentiation (Pfundmair, Rimpel, Duffy, & Zwarg, 2018),
an effect that was associated with reduced medial prefrontal cortex
activity (Zhao, Luo, et al., 2016; Zhao, Yao, et al., 2016). Further
experiments emphasized its capacity to re-balance the self–other dis-
tinction by decreasing self- and increasing other-related processing
(Liu, Sheng, Woodcock, & Han, 2013). A smaller P300-amplitude dif-
ference in response to self- and other-stimuli was also found in medi-
tators and negatively correlated with length of practice (Trautwein,
Naranjo, & Schmidt, 2016). Meditation-related neuroplasticity may
lead to a de-emphasis of the individual self in favor of more
interdependent aspects of self–other identity (Neff, 2008). Self–other
connectedness was suggested as a general mechanism of prosocial
meditation effects (Trautwein, Naranjo, & Schmidt, 2014). Shared
neural representations of self and other involving mirror neurons and
action-perception models are a proposed basis for prosocial human
behavior, such as altruism or empathy (Decety & Sommerville, 2003;
Lawrence et al., 2006). For example, overlapping self–other brain
areas were found for empathetic experiences (Singer et al., 2004) and
in extreme altruists (Brethel-Haurwitz et al., 2017). The action of psy-
chedelics in humans may produce these rare instances when a sense
of shared awareness can transcend self–other differences. The feeling
of connectedness or unity occurring under psilocybin may be inter-
preted as a shift in the meaning of “other” anchored in P300 neuronal
processing. The transient functional modulation of brain dynamics
may result in further cognitive and emotional reappraisals. Accord-
ingly, psilocybin can induce a positive emotional processing bias by
modulating the P300 amplitude (Kometer et al., 2012) and promote
positive attitudes and behaviors toward self and others (Pokorny, Pre-
ller, Kraehenmann, & Vollenweider, 2016; Preller et al., 2016) that are
observable even months after psilocybin intake (Griffiths et al., 2011).
Our data furthermore showed a general psilocybin effect in the
N100 timeframe (which, however, did not meet the global duration
statistics criterion) and its link with disembodiment. This suggests that
an early sensory and more bodily anchored sense of self is also altered
by psilocybin during states of perceived loosening of corporeal bound-
aries. A distinction between the minimal (core) self, an immediate sub-
ject of experience rooted in a bodily subject of action, as opposed to
the mental self, which engages more elaborative representational
aspects, has been delineated in recent conceptual and experimental
frameworks (Blanke, 2012; Gallagher, 2000). Indeed, the N100 com-
ponent has been associated with a basic form of self-awareness (Hubl
et al., 2014), and self-recognition was found to require at least two
components: self-awareness of one's body and one's action (van den
Bos & Jeannerod, 2002). A rich literature underlines the role of N100
in explaining the prereflective self-awareness of action and source dis-
tinction in the context of the forward model of motor control
(Blakemore, Wolpert, & Frith, 2002; Wolpert & Miall, 1996). This
framework aims to both explain the origination of the basic sense of
self while clarifying disturbances in self-experience (Ford, Roach, &
Mathalon, 2010). The present whole-scalp topographic analysis did
not specifically target the mechanism of corollary discharge, which
reflects a local sensory-motor interplay. Still, our study may motivate
future investigations of these bodily aspects of psychedelic effects, in
consideration of this and other neurophysiological mechanisms. Addi-
tionally, a single process early in the neural processing stream
(e.g., N100) may further modulate later stages through co-dependent
temporal properties of the signal (Burgess, 2012; Taylor et al., 2019).
The disembodiment aspect may also further modulate perception
through a lessened corporeal reference and desynchronization of pre-
dictive coding (Giummarra, Gibson, Georgiou-Karistianis, & Bradshaw, 2008;
Ho, Preller, & Lenggenhager, 2020).
4.5 | Cross-domain relevance
The present findings are particularly relevant for social and cognitive
neuroscience, biological psychiatry, and clinical applications. The
psilocybin-induced effect known as “ego-dissolution” has been con-
sidered from various perspectives: phenomenology (Preller &
Vollenweider, 2016), descriptive psychopathology (Scharfetter, 1981),
as a core feature of spiritual experience (Griffiths, Richards, McCann, &
Jesse, 2006), in psychodynamic terms as distortion of ego boundaries
(Fischman, 1983), and in brain imaging studies (Lebedev et al., 2015).
Our study extends these results by offering a spatiotemporal brain
mechanism underlying this peculiar form of human cognition. Further,
the study adds to the scientific understanding of “self,” “other,” and
the self–other overlap, an effect that may modulate social cognition.
Notably, patients in a recent clinical trial of psilocybin for therapy-
resistant depression reported a sense of connectedness that endured
posttreatment (Carhart-Harris, Erritzoe, Haijen, Kaelen, & Watts, 2018).
A feeling of disconnection characterizes many psychiatric conditions,
particularly depression (Karp, 2016), while connectedness was identi-
fied as a mediator of psychological well-being (Lee, Dean, & Jung, 2008)
and recovery in mental health (Leamy, Bird, Le Boutillier, Williams, &
Slade, 2011). The effect may reflect a mechanism of action and become
an instrument of interpersonal understanding in psychedelic-assisted
therapy, as an extension of the recent interest in psychedelics in clinical
settings (Schenberg, 2018).
The concept of the self has become popular for its explanatory
clinical value and as a research topic in psychiatry (Kircher &
David, 2003). Maladaptive modes of self-cognition may be encoun-
tered in autism (Lombardo et al., 2010), in major depression (Sheline
et al., 2009), and as the core phenotypic marker in schizophrenia
(Sass & Parnas, 2003). Treatment of these conditions may profit from
a better understanding of the mechanisms underlying self-processing.
Therapeutic applications of psilocybin may utilize its effects on exces-
sive self-focus, ruminative brooding, sense of disconnection, and cog-
nitive rigidity.
4.6 | Limitations
Like most research in the area of cognitive neuroscience, this work
has some limitations. We cannot fully rule out the possibility that the
observed effects of psilocybin on “self”/”other” processing are driven
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by drug-induced attentional deficits or task disengagement. While psi-
locybin can indeed modulate certain aspects of attention (Carter
et al., 2005), our data reveal its differential effects on the processing
of “self” and “other” as a statistically significant treatment × condition
interaction. No main effect of drug on topography was found in the
P300 timeframe. The differential effect of psilocybin is further
supported by post hoc t-maps and CSD results. Additionally, in the
analysis of the behavioral task data, we also identified a significant
treatment × condition interaction paralleling the EEG findings, while
the drug effect was nominally nonsignificant without pitch conditions,
with no concomitant increase in unsure responses. While the verbal-
auditory domain seems particularly unstable and affected in psychiat-
ric conditions associated with alterations in self-experience (Strik,
Dierks, Hubl, & Horn, 2008), future studies should also consider other
perceptual domains (e.g., visual or explicitly motor). While psilocybin
may alter vocalizations, the visual evaluation of voice spectra did not
suggest this possibility. It also remains unknown whether similar con-
clusions apply to other psychedelic-like tryptamines. Further con-
straints relate to design in the context of psychoactive compounds.
These include possible carry-over effects from the crossover design
and the time gap between the two sessions, as well as the efficacy of
double-blind procedures for testing substances with conspicuous
effects. However, an inert placebo offered the cleanest control condi-
tion in this experiment.
4.7 | Conclusions
Self is a pervasive experience of being consistent across time, subject
of one's own actions, and distinct from others. Using a data-driven
approach, with the advantage of the high temporal resolution of EEG,
we demonstrated psilocybin abolishes distinctiveness of self-related
scalp configurations via P300-related mechanisms in association with
altered activity in the supragenual cingulate cortex and insula. This
study advances the current mechanistic understanding of self–other
processing and the biological foundations of subjectivity. Pharmaco-
logical stimulation with the serotonergic psychedelic psilocybin offers
an experimentally valid platform for perturbing and quantifying
altered self-referential processing.
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